Vir Biotechnology to Test COVID-19 Antibody ‘In the Summer’
March 27, 2020
By Neozene

This article originally appeared in FierceBiotech and was written by Ben Adams One-quarter of the world is now hunkering down to weather the infectious storm that is COVID-19, and Vir’s insistence on the importance of infectious disease research is prescient to say the least. Today, the biotech, helmed by former Biogen CEO George Scangos, says it has mapped out “multiple antibodies” that can “neutralize” SARS-CoV-2, the virus causing COVID-19. The San Francisco biotech says it will kick-start a phase 1/2 clinical test as early as this summer, in “3 to 5 months.” Vir

Read More

How Neozene is Responding to COVID-19
March 20, 2020
By Neozene

With the ongoing threat of COVID-19 (“Coronavirus”) sweeping the state, country and world, we would like to give you a brief update on how we’re responding to the crisis.   First and foremost, we are still going strong, but the health and safety of our employees and customers remains our top priority—as such, we have sent the majority of our staff home so they can work remotely. The work we do is critical to biomedical and pharmacological research, and we’re committed to working on solutions to ease the burden of

Read More

Gates Foundation Will Deliver At-Home Coronavirus Test Kits to Seattle
March 10, 2020
By Neozene

This article originally appeared in FierceBiotech and was written by Conor Hale The Bill & Melinda Gates Foundation has made new commitments to respond to the spread of the novel coronavirus in its hometown of Seattle, including new public health funding and a project to provide at-home testing kits. According to a report by The Seattle Times, the test packages will include nose swabs that can be mailed to the University of Washington (UW) for analysis, with the goal of processing thousands of tests per day. The project is pivoting resources

Read More